IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 108 filers reported holding IGM BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $626,250 | -9.5% | 75,000 | 0.0% | 0.01% | -12.5% |
| Q2 2023 | $692,250 | -67.2% | 75,000 | -51.2% | 0.01% | -72.4% |
| Q1 2023 | $2,113,556 | -17.2% | 153,825 | +2.6% | 0.03% | -14.7% |
| Q4 2022 | $2,551,500 | -43.9% | 150,000 | -25.0% | 0.03% | -46.9% |
| Q3 2022 | $4,549,000 | +26.1% | 200,047 | 0.0% | 0.06% | +14.3% |
| Q2 2022 | $3,607,000 | -66.5% | 200,047 | -50.4% | 0.06% | -68.0% |
| Q1 2022 | $10,783,000 | -8.9% | 403,401 | 0.0% | 0.18% | +3.6% |
| Q4 2021 | $11,832,000 | -68.4% | 403,401 | -29.1% | 0.17% | -72.3% |
| Q3 2021 | $37,418,000 | -39.7% | 569,009 | -23.7% | 0.61% | -47.1% |
| Q2 2021 | $62,017,000 | +87.8% | 745,393 | +73.1% | 1.16% | +57.7% |
| Q1 2021 | $33,029,000 | -30.8% | 430,683 | -20.3% | 0.73% | -42.1% |
| Q4 2020 | $47,713,000 | +615.2% | 540,416 | +498.0% | 1.26% | +477.6% |
| Q3 2020 | $6,671,000 | – | 90,378 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,425,455 | $225,258,000 | 3.93% |
| Artal Group S.A. | 1,350,000 | $88,776,000 | 1.99% |
| Eagle Bay Advisors LLC | 35,295 | $2,321,000 | 1.30% |
| Cormorant Asset Management, LP | 350,000 | $23,016,000 | 0.94% |
| Baker Brothers Advisors | 3,156,102 | $207,545,000 | 0.91% |
| Bruce & Co., Inc. | 55,000 | $3,616,000 | 0.77% |
| Altium Capital Management LP | 42,473 | $2,793,000 | 0.73% |
| HighVista Strategies LLC | 15,446 | $1,016,000 | 0.67% |
| Woodline Partners LP | 569,009 | $37,418,000 | 0.61% |
| Ikarian Capital, LLC | 100,000 | $6,576,000 | 0.46% |